Researchers from both the CDC and the National Institutes of Health tested 1,868 blood samples of people seeking care for possible Ebola infections. Ebola was confirmed in 1,182 samples, 956 were tested for Plasmodium parasites and 185 came back with positive tests for parasites. The survival rate among patients infected with Ebola sans parasites was 46 percent. Among those with concurrent infections, 58 percent survived. Those with the highest levels of Plasmodium had an 83 percent survival rate.
The study’s authors concluded, “Plasmodium species parasitemia is associated with an increase in the probability of surviving Ebola virus infection. More research is needed to understand the molecular mechanism underlying this remarkable phenomenon and translate it into treatment options for Ebola virus infection.”
More articles on infection control:
Obesity hinders flu vaccine effectiveness
US pediatricians say vaccination rates remain steady, but so do parental concerns
Outlook ‘cautiously optimistic’ in new brain-eating amoeba case
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
